Standard practice after bariatric surgery includes routine b12 monitoring and supplementation
This solution is the most widely recommended reconstitution solvent for research peptides due to its compatibility with a broad range of compounds, its multi-use capability, and its stable preservation profile
FOXO4-DRI is a large peptide (~5382 Da, 48 amino acids) with a critical structural modification: the D-Retro-Inverso (DRI) design uses D-amino acids in reversed sequence to confer protease resistance while maintaining the 3D spatial arrangement needed for target binding
In physiological conditions, it exists primarily as the copper chelate GHK-Cu
### Alternative: 2.5mg/mL (Better for Low Doses) | Vial Size | BAC Water to Add | Concentration | Volume per 0.5mg Dose | |-----------|-----------------|---------------|-----------------------| | 5mg | 2.0mL | 2.5mg/mL | 0.20mL | | 10mg | 4.0mL | 2.5mg/mL | 0.20mL | This lower concentration produces larger injection volumes easier to measure precisely, but more volume per shot
Network meta-analysis showed no evidence of differences among all possible comparisons for secondary outcomes (MCV, homocysteine levels, platelet counts, and WBC counts)